94 companies

Bruker

Market Cap: US$5.6b

Develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally.

BRKR

US$37.40

7D

0.7%

1Y

-41.3%

Dong-A Socio Holdings

Market Cap: ₩720.2b

Engages in the pharmaceutical business in South Korea.

A000640

₩111,900.00

7D

8.1%

1Y

13.0%

Zhejiang Starry PharmaceuticalLtd

Market Cap: CN¥4.7b

Engages in the research and development, production, and sale of X-CT non-ionic contrast agents and fluoroquinolones drugs and intermediates in China and internationally.

603520

CN¥10.80

7D

8.3%

1Y

1.7%

Genovis AB (publ.)

Market Cap: SEK 1.7b

Develops and sells tools for the development of new treatment methods and diagnostics in North America, Europe, and Asia.

GENO

SEK 26.00

7D

-0.6%

1Y

-33.6%

Selvita

Market Cap: zł554.3m

Operates as a contract research organization worldwide.

SLV

zł30.20

7D

-8.2%

1Y

-52.4%

Aroa Biosurgery

Market Cap: AU$160.4m

Develops, manufactures, and sells medical devices for wound and soft tissue repair using extracellular matrix (ECM) technology in the United States and internationally.

ARX

AU$0.47

7D

0%

1Y

-13.9%

Diaceutics

Market Cap: UK£106.9m

A diagnostic commercialisation company, provides data, data analytics, and implementation services for pharma and biotech companies.

DXRX

UK£1.27

7D

-9.0%

1Y

-4.5%

ECO Animal Health Group

Market Cap: UK£41.3m

Develops, registers, and markets pharmaceutical products for animals worldwide.

EAH

UK£0.61

7D

0%

1Y

-52.3%

Nanjing Vazyme Biotech

Market Cap: CN¥9.2b

Offers technology solutions for life science, biomedicine, and in vitro diagnostics.

688105

CN¥23.01

7D

7.8%

1Y

2.9%

Knight Therapeutics

Market Cap: CA$572.9m

Focuses on acquiring, in-licensing, out-licensing, marketing, and commercializing prescription pharmaceutical products in Canada and Latin America.

GUD

CA$5.80

7D

0%

1Y

1.2%

Indoco Remedies

Market Cap: ₹25.7b

Manufactures, markets, and sells formulations and active pharmaceutical ingredients in India and internationally.

INDOCO

₹279.10

7D

12.5%

1Y

-6.4%

Laurus Labs

Market Cap: ₹334.3b

Manufactures and sells medicines and active pharmaceutical ingredients (APIs) in India and internationally.

LAURUSLABS

₹619.60

7D

3.0%

1Y

53.3%

Swedencare

Market Cap: SEK 6.3b

Develops, manufactures, markets, and sells animal healthcare products for cats, dogs, and horses in North America, Europe, and internationally.

SECARE

SEK 39.55

7D

-0.8%

1Y

-33.3%

AcrobiosystemsLtd

Market Cap: CN¥6.3b

Engages in the development and manufacture of recombinant proteins, antibodies, and other biological reagents for pharmaceutical and biotechnology companies, and scientific research institutions.

301080

CN¥52.62

7D

3.4%

1Y

35.4%

Hangzhou Bio-Sincerity Pharma-TechLtd

Market Cap: CN¥4.7b

Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd.

301096

CN¥42.93

7D

10.1%

1Y

-30.9%

Jiangxi Synergy Pharmaceutical

Market Cap: CN¥3.4b

Manufactures and sells APIs worldwide.

300636

CN¥8.08

7D

8.9%

1Y

-19.5%

EZZ Life Science Holdings

Market Cap: AU$72.9m

Engages in formulation, production, marketing, and sale of the health and wellbeing products in Australia, New Zealand, Mainland China, and internationally.

EZZ

AU$1.55

7D

2.0%

1Y

49.3%

Navamedic

Market Cap: NOK 393.9m

A pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Norway, Sweden, Denmark, Finland, the Netherlands, and internationally.

NAVA

NOK 22.30

7D

1.8%

1Y

-35.4%

Shanghai Allist Pharmaceuticals

Market Cap: CN¥43.0b

Shanghai Allist Pharmaceuticals Co., Ltd.

688578

CN¥95.46

7D

11.0%

1Y

56.5%

Nxera Pharma

Market Cap: JP¥84.8b

Develops and sells pharmaceutical products in Japan, the United States, Germany, Switzerland, Bermuda, and the United Kingdom.

4565

JP¥943.00

7D

15.4%

1Y

-37.1%

Formycon

Market Cap: €439.7m

A biotechnology company, develops biosimilar drugs in Germany and Switzerland.

FYB

€24.90

7D

7.1%

1Y

-47.0%

Organogenesis Holdings

Market Cap: US$356.5m

A regenerative medicine company, develops, manufactures, and commercializes products for the advanced wound care, and surgical and sports medicine markets in the United States.

ORGO

US$2.81

7D

-2.1%

1Y

6.0%

Page 3 of 3